ArticleDiagnostics (Basel, Switzerland)2023
Early Melanoma Detection Based on a Hybrid YOLOv5 and ResNet Technique.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- A YOLOv8 deep learning model for detecting labral injury via hip magnetic resonance imaging.Quantitative imaging in medicine and surgery · 2026Article
- Artificial Intelligence in Dermatopathology: An Update and Review of the Current Literature.Diagnostics (Basel, Switzerland) · 2026Review
- Artificial Intelligence Powered Real-Time Coronary Stenosis Recognition and Quantification in Angiography.Journal of imaging informatics in medicine · 2026Article
- A deep learning-based radiomics model for noninvasive diagnosis of melanoma.Melanoma research · 2026Article
- SkinDet-YOLO: a context- and boundary-aware yolov8-based framework for skin disease detection.Frontiers in oncology · 2026Article
- Interpretable multi-model deep learning framework for automated four-class diagnosis of ocular toxoplasmosis using fundus imaging.Scientific reports · 2025Article
- Early-Stage Melanoma Benchmark Dataset.Cancers · 2025Article
- Advances in computer vision and deep learning-facilitated early detection of melanoma.Briefings in functional genomics · 2025Review
- A multi-module enhanced YOLOv8 framework for accurate AO classification of distal radius fractures: SCFAST-YOLO.Frontiers in medicine · 2025Article
- Advancements in acne detection: application of the CenterNet network in smart dermatology.Frontiers in medicine · 2024Article
- AI in dermatology: a comprehensive review into skin cancer detection.PeerJ. Computer science · 2024Article
- Enhanced skin cancer diagnosis: a deep feature extraction-based framework for the multi-classification of skin cancer utilizing dermoscopy images.Frontiers in medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer, specifically melanoma, is a serious health issue that arises from the melanocytes, the cells that produce melanin, the pigment responsible for skin color. With skin cancer on the rise, the timely identification of skin lesions is crucial for effective treatment. However, the similarity between some skin lesions can result in misclassification, which is a significant problem. It is important to note that benign skin lesions are more prevalent than malignant ones, which can lead to overly cautious algorithms and incorrect results. As a solution, researchers are developing computer-assisted diagnostic tools to detect malignant tumors early. First, a new model based on the combination of "you only look once" (YOLOv5) and "ResNet50" is proposed for melanoma detection with its degree using humans against a machine with 10,000 training images (HAM10000). Second, feature maps integrate gradient change, which allows rapid inference, boosts precision, and reduces the number of hyperparameters in the model, making it smaller. Finally, the current YOLOv5 model is changed to obtain the desired outcomes by adding new classes for dermatoscopic images of typical lesions with pigmented skin. The proposed approach improves melanoma detection with a real-time speed of 0.4 MS of non-maximum suppression (NMS) per image. The performance metrics average is 99.0%, 98.6%, 98.8%, 99.5, 98.3%, and 98.7% for the precision, recall, dice similarity coefficient (DSC), accuracy, mean average precision (MAP) from 0.0 to 0.5, and MAP from 0.5 to 0.95, respectively. Compared to current melanoma detection approaches, the provided approach is more efficient in using deep features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.